bluebird bio, Inc. (BLUE) is a biotech company, and it keeps losing money. Bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases.
bluebird bio, Inc. (BLUE) is a biotech company, and it keeps losing money. Bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic and rare diseases.
This company (Bluebird) keeps losing money, sell it when the Bio sector starts to drop.